Characterization of the CYP2D6*29 allele commonly present in a black Tanzanian population causing reduced catalytic activity (vol 11, pg 417, 2001)

被引：0
|
作者：
Wennerholm, A
Johansson, I
Hidestrand, M
Bertilsson, L
Gustafsson, LL
IngelmanSundberg, M
机构：
来源：
PHARMACOGENETICS | 2001年 / 11卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：743 / 743
页数：1
相关论文
共 27 条
  • [21] RETRACTION: CYP2D6 T188C variant is associated with lung cancer risk in the Chinese population (Retraction of Vol 34, Pg 2189, 2013)
    Stigbrand, Torgny
    TUMOR BIOLOGY, 2017,
  • [22] Nicotine metabolism and CYP2A6 activity in a population of black African descent: Impact of gender and light smoking (vol 89, pg 24, 2007)
    Mwenifumbo, Jill C.
    Sellers, Edward M.
    Tyndale, Rachel F.
    DRUG AND ALCOHOL DEPENDENCE, 2009, 104 (1-2) : 185 - 185
  • [23] CYP2D6 genotyping analysis and functional characterization of novel allelic variants in a Ni-Vanuatu and Kenyan population by assessing dextromethorphan O-demethylation activity
    Rico, Evelyn Marie Gutierrez
    Kikuchi, Aoi
    Saito, Takahiro
    Kumondai, Masaki
    Hishinuma, Eiji
    Kaneko, Akira
    Chan, Chim Wai
    Gitaka, Jesse
    Nakayoshi, Tomoki
    Oda, Akifumi
    Saito, Sakae
    Hirasawa, Noriyasu
    Hiratsuka, Masahiro
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : 89 - 101
  • [24] Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population(vol 220, pg 1761, 2019)
    Spring, Michele D.
    Sousa, Jason C.
    Li, Qigui
    Darko, Christian A.
    Morrison, Meshell N.
    Marcsisin, Sean R.
    Mills, Kristin T.
    Potter, Brittney M.
    Paolino, Kristopher M.
    Twomey, Patrick S.
    Moon, James E.
    Tosh, Donna M.
    Cicatelli, Susan B.
    Froude, Jeffrey W.
    Pybus, Brandon S.
    Oliver, Thomas G.
    McCarthy, William F.
    Waters, Norman C.
    Smith, Philip L.
    Reichard, Gregory A.
    Bennett, Jason W.
    JOURNAL OF INFECTIOUS DISEASES, 2020, 221 (07): : 1204 - 1204
  • [25] Composite Functional Genetic and Comedication CYP2D6 Activity Score in Predicting Tamoxifen Drug Exposure Among Breast Cancer Patients (vol 50, pg 450, 2010)
    Borges, S.
    Desta, Z.
    Jin, Y.
    Faouzi, A.
    Robarge, J. D.
    Philip, S.
    Nguyen, A.
    Stearns, V
    Hayes, D.
    Rae, J. M.
    Skaar, T. C.
    Flockhart, D. A.
    Li, L.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (06): : 725 - 725
  • [26] Genotype and co-medication dependent CYP2D6 metabolic activity: effects on serum concentrations of aripiprazole, haloperidol, risperidone, paliperidone and zuclopenthixol (vol 72, pg 175, 2016)
    Patteet, Lisbeth
    Haufroid, Vincent
    Maudens, Kristof
    Sabbe, Bernard
    Morrens, Manuel
    Neels, Hugo
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (01) : 127 - 127
  • [27] The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes (Reprinted from Br J Clin Pharmacol, vol 34, pg 262-265, 1992)
    Crewe, HK
    Lennard, MS
    Tucker, GT
    Woods, FR
    Haddock, RE
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (07) : S744 - S747
123